PMC:7283670 / 53073-53207
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T313 | 87-105 | Disease | denotes | hypercoagulability | http://purl.obolibrary.org/obo/MONDO_0002305 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 59-76 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T30 | 59-76 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T596 | 0-134 | Sentence | denotes | Dipyridamole adjunctive therapy could significantly reduce viral replication, inhibits hypercoagulability and improves immune recovery |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T208 | 87-105 | Phenotype | denotes | hypercoagulability | http://purl.obolibrary.org/obo/HP_0100724 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1220 | 0-12 | Chemical | denotes | Dipyridamole | MESH:D004176 |
| 1415 | 87-105 | Disease | denotes | hypercoagulability | MESH:D019851 |